Neuland Laboratories Limited (NEULANDLAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Neuland Laboratories Limited (NEULANDLAB) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-367.47 Million ≈ $-3.97 Million USD) by net assets (Rs16.20 Billion ≈ $175.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NEULANDLAB equity to assets ratio to measure how much of total assets are equity-financed.
Neuland Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2026)
This chart illustrates how Neuland Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Neuland Laboratories Limited to evaluate the quality of earnings relative to operating cash generation.
Neuland Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuland Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quaker Chemical Corporation
NYSE:KWR
|
0.003x |
|
Mivne Real Estate KD Ltd
TA:MVNE
|
0.028x |
|
People.Cn Co Ltd
SHG:603000
|
0.020x |
|
Fujian Newland Computer Co Ltd
SHE:000997
|
-0.028x |
|
Genting Malaysia Bhd
KLSE:4715
|
0.065x |
|
Extendicare Inc
TO:EXE
|
0.082x |
|
Sany Heavy Energy Co. Ltd. A
SHG:688349
|
N/A |
|
DHT Holdings Inc
NYSE:DHT
|
0.064x |
Annual Cash Flow Conversion Efficiency for Neuland Laboratories Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of Neuland Laboratories Limited from 2006 to 2026. For the full company profile with market capitalisation and key ratios, see Neuland Laboratories Limited (NEULANDLAB) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs18.74 Billion ≈ $202.72 Million |
Rs3.38 Billion ≈ $36.58 Million |
0.180x | -13.31% |
| 2025-03-31 | Rs15.25 Billion ≈ $164.90 Million |
Rs3.17 Billion ≈ $34.32 Million |
0.208x | +4.42% |
| 2024-03-31 | Rs12.83 Billion ≈ $138.72 Million |
Rs2.56 Billion ≈ $27.65 Million |
0.199x | -16.93% |
| 2023-03-31 | Rs9.94 Billion ≈ $107.51 Million |
Rs2.39 Billion ≈ $25.80 Million |
0.240x | +244.27% |
| 2022-03-31 | Rs8.41 Billion ≈ $90.90 Million |
Rs585.81 Million ≈ $6.34 Million |
0.070x | -71.05% |
| 2021-03-31 | Rs7.86 Billion ≈ $85.05 Million |
Rs1.89 Billion ≈ $20.48 Million |
0.241x | +198.11% |
| 2020-03-31 | Rs7.10 Billion ≈ $76.78 Million |
Rs573.41 Million ≈ $6.20 Million |
0.081x | -19.21% |
| 2019-03-31 | Rs6.99 Billion ≈ $75.63 Million |
Rs699.07 Million ≈ $7.56 Million |
0.100x | +395.08% |
| 2018-03-31 | Rs5.58 Billion ≈ $60.35 Million |
Rs112.68 Million ≈ $1.22 Million |
0.020x | -71.52% |
| 2017-03-31 | Rs5.46 Billion ≈ $59.01 Million |
Rs386.81 Million ≈ $4.18 Million |
0.071x | -70.48% |
| 2016-03-31 | Rs1.87 Billion ≈ $20.18 Million |
Rs448.26 Million ≈ $4.85 Million |
0.240x | +194.71% |
| 2015-03-31 | Rs1.62 Billion ≈ $17.48 Million |
Rs131.72 Million ≈ $1.42 Million |
0.081x | -77.18% |
| 2014-03-31 | Rs1.24 Billion ≈ $13.44 Million |
Rs443.82 Million ≈ $4.80 Million |
0.357x | +39.32% |
| 2013-03-31 | Rs1.00 Billion ≈ $10.83 Million |
Rs256.77 Million ≈ $2.78 Million |
0.256x | -60.26% |
| 2012-03-31 | Rs764.81 Million ≈ $8.27 Million |
Rs493.39 Million ≈ $5.34 Million |
0.645x | +39.53% |
| 2011-03-31 | Rs739.68 Million ≈ $8.00 Million |
Rs341.98 Million ≈ $3.70 Million |
0.462x | +109.13% |
| 2010-03-31 | Rs688.95 Million ≈ $7.45 Million |
Rs152.31 Million ≈ $1.65 Million |
0.221x | -22.15% |
| 2009-03-31 | Rs758.08 Million ≈ $8.20 Million |
Rs215.28 Million ≈ $2.33 Million |
0.284x | +186.68% |
| 2008-03-31 | Rs686.76 Million ≈ $7.43 Million |
Rs68.03 Million ≈ $735.72K |
0.099x | +218.14% |
| 2007-03-31 | Rs596.77 Million ≈ $6.45 Million |
Rs-50.04 Million ≈ $-541.16K |
-0.084x | -151.12% |
| 2006-03-31 | Rs523.07 Million ≈ $5.66 Million |
Rs85.81 Million ≈ $927.97K |
0.164x | -- |
About Neuland Laboratories Limited
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.